BiotechTube
Home/Kaerus Bioscience/Robert H. Ring
RH

Robert H. Ring

Chief Executive Officer

Kaerus Bioscience

Therapeutic Areas

Neurodevelopmental DisordersRare Genetic Diseases

Kaerus Bioscience Pipeline

DrugIndicationPhase
KER-0193Fragile X syndromePreclinical
BK Channel ModulatorKCNMA1-linked ChannelopathiesPreclinical

Leadership Team at Kaerus Bioscience

VG
Valentin Gribkoff
Ion Channel Pharmacology
MC
Marc Ceusters
Head of Development
NS
Nicholas Stern
Chief Financial Officer
View full Kaerus Bioscience profile